• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨相关事件对转移性前列腺癌患者健康相关生活质量的意义。

The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer.

作者信息

Weinfurt K P, Li Y, Castel L D, Saad F, Timbie J W, Glendenning G A, Schulman K A

机构信息

Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA.

出版信息

Ann Oncol. 2005 Apr;16(4):579-84. doi: 10.1093/annonc/mdi122. Epub 2005 Feb 25.

DOI:10.1093/annonc/mdi122
PMID:15734776
Abstract

BACKGROUND

We examined the clinical relevance of skeletal-related events (SREs) for health state preferences, pain and health-related quality of life in patients with advanced prostate cancer and a history of bone metastases.

PATIENTS AND METHODS

Data were from a clinical trial of zoledronic acid versus placebo in the treatment of SREs associated with advanced prostate cancer metastatic to bone. Patients (n=248) were included if they experienced an SRE during the study. Outcome measures were assessed at fixed intervals. We used mixed-effects models to estimate changes in outcomes after each patient's first SRE.

RESULTS

There were clinically meaningful and statistically significant declines in physical well-being after: radiation and pathologic fractures; functional well-being after radiation; and emotional well-being after radiation and pathologic fractures. There also were meaningful and significant declines in preference and utility scores after radiation and fracture. Pain intensity declined after radiation, but not after other SREs; no other pain measure changed substantively.

CONCLUSIONS

SREs have important and significant effects on measures of health-related quality of life in men with prostate cancer. Treatments that prevent SREs may not demonstrate corresponding effects on outcomes if the effects of SREs occur between scheduled outcome assessments. Implications for trial design are discussed.

摘要

背景

我们研究了骨相关事件(SREs)对于晚期前列腺癌且有骨转移病史患者的健康状态偏好、疼痛及健康相关生活质量的临床相关性。

患者与方法

数据来自一项唑来膦酸对比安慰剂治疗骨转移相关晚期前列腺癌SREs的临床试验。若患者在研究期间经历了一次SREs,则纳入研究(n = 248)。在固定时间间隔评估结局指标。我们使用混合效应模型来估计每位患者首次发生SREs后结局的变化。

结果

在发生以下情况后,身体幸福感出现了具有临床意义且在统计学上显著的下降:放疗和病理性骨折后;放疗后的功能幸福感;放疗和病理性骨折后的情绪幸福感。在放疗和骨折后,偏好和效用评分也出现了有意义且显著的下降。放疗后疼痛强度下降,但其他SREs后未下降;其他疼痛指标无实质性变化。

结论

SREs对前列腺癌男性患者的健康相关生活质量指标有重要且显著的影响。如果SREs的影响发生在预定的结局评估之间,预防SREs的治疗可能不会在结局上显示出相应的效果。讨论了对试验设计的影响。

相似文献

1
The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer.骨相关事件对转移性前列腺癌患者健康相关生活质量的意义。
Ann Oncol. 2005 Apr;16(4):579-84. doi: 10.1093/annonc/mdi122. Epub 2005 Feb 25.
2
Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate cancer.唑来膦酸预防晚期前列腺癌骨并发症的临床获益
Clin Prostate Cancer. 2005 Jun;4(1):31-7. doi: 10.3816/cgc.2005.n.009.
3
Opioid Use Among Metastatic Prostate Cancer Patients With Skeletal-related Events.发生骨相关事件的转移性前列腺癌患者的阿片类药物使用情况
Clin Ther. 2016 Aug;38(8):1880-9. doi: 10.1016/j.clinthera.2016.06.018. Epub 2016 Jul 29.
4
Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer.骨骼病变对转移性前列腺癌患者纵向患者报告结局及生存的影响。
Support Care Cancer. 2007 Jul;15(7):869-76. doi: 10.1007/s00520-006-0203-x.
5
Burden of skeletal-related events in prostate cancer: unmet need in pain improvement.前列腺癌骨相关事件的负担:疼痛改善方面未满足的需求。
Support Care Cancer. 2015 Jan;23(1):237-47. doi: 10.1007/s00520-014-2437-3. Epub 2014 Oct 2.
6
Bisphosphonates and other bone agents for breast cancer.用于乳腺癌的双膦酸盐及其他骨药物。
Cochrane Database Syst Rev. 2012 Feb 15(2):CD003474. doi: 10.1002/14651858.CD003474.pub3.
7
Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastases.唑来膦酸在预防骨转移患者骨骼并发症方面的持续益处。
Clin Genitourin Cancer. 2007 Sep;5(6):390-6. doi: 10.3816/CGC.2007.n.022.
8
The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.患有前列腺癌骨转移的医疗保险参保者中骨相关事件的临床和经济影响。
Oncologist. 2016 Mar;21(3):320-6. doi: 10.1634/theoncologist.2015-0327. Epub 2016 Feb 10.
9
Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?骨骼相关事件是否可预测转移性去势抵抗性前列腺癌男性患者的总生存期?
Prostate Cancer Prostatic Dis. 2016 Dec;19(4):380-384. doi: 10.1038/pcan.2016.26. Epub 2016 Jul 5.
10
Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid.晚期乳腺癌的骨相关并发症和生活质量:地舒单抗对比唑来膦酸的随机 III 期临床试验结果。
Clin Cancer Res. 2012 Sep 1;18(17):4841-9. doi: 10.1158/1078-0432.CCR-11-3310. Epub 2012 Aug 14.

引用本文的文献

1
Post-marketing surveillance of radium-223 chloride in Japanese patients with castration-resistant prostate cancer with bone metastasis-final analysis of 3-year extended follow-up focusing on bone fractures.日本去势抵抗性前列腺癌伴骨转移患者中氯化镭-223的上市后监测——聚焦骨折的3年延长随访最终分析
Int J Clin Oncol. 2025 Aug 8. doi: 10.1007/s10147-025-02846-7.
2
Patient, caregiver experiences in metastatic castration-resistant prostate cancer: insights from a multi-national survey.转移性去势抵抗性前列腺癌患者及照料者的经历:一项多国调查的见解
Future Oncol. 2025 Jul;21(16):2053-2066. doi: 10.1080/14796694.2025.2510890. Epub 2025 Jun 2.
3
Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation.
英国前列腺癌转移在诊断时的地理、社会经济和人口统计学不平等:一项基于人群的评估。
BMJ Oncol. 2025 Apr 1;4(1):e000643. doi: 10.1136/bmjonc-2024-000643. eCollection 2025.
4
Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer.去势抵抗性转移性前列腺癌真实世界患者中骨改良药物的应用及癌症控制结局
JBMR Plus. 2024 Nov 26;9(1):ziae157. doi: 10.1093/jbmrpl/ziae157. eCollection 2025 Jan.
5
Temporary halo fixation and radiotherapy as alternative to long-construct spondylodesis in patients with multiple unstable cervical metastases.对于患有多处不稳定颈椎转移瘤的患者,临时颅骨牵引固定和放射治疗可替代长节段脊柱融合术。
Clin Transl Radiat Oncol. 2024 Sep 11;49:100858. doi: 10.1016/j.ctro.2024.100858. eCollection 2024 Nov.
6
Bridging the gap - Establishing a dental-oncology service in a cancer centre.弥合差距 - 在癌症中心建立牙科肿瘤服务。
Support Care Cancer. 2024 Sep 28;32(10):693. doi: 10.1007/s00520-024-08872-x.
7
Impacts of radiation therapy on quality of life and pain relief in patients with bone metastases.放射治疗对骨转移患者生活质量和疼痛缓解的影响。
World J Orthop. 2024 Sep 18;15(9):841-849. doi: 10.5312/wjo.v15.i9.841.
8
Real-World Evaluation of Primary Versus Secondary Prevention of Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer.转移性去势抵抗性前列腺癌中骨骼相关事件的一级预防与二级预防的真实世界评估。
Oncologist. 2024 Oct 3;29(10):878-886. doi: 10.1093/oncolo/oyae036.
9
Do metastatic volumes measured in breast cancer patients with bone metastases correlate with the numbers of skeletal and extraskeletal events?骨转移乳腺癌患者的转移瘤体积与骨骼和骨骼外事件的数量是否相关?
Jt Dis Relat Surg. 2024 Jan 1;35(1):105-111. doi: 10.52312/jdrs.2023.1333. Epub 2023 Nov 2.
10
Denosumab administration for bone metastases from solid tumors: a retrospective cross-sectional study.实体瘤骨转移患者使用地舒单抗治疗的回顾性横断面研究。
BMC Cancer. 2023 Oct 18;23(1):999. doi: 10.1186/s12885-023-11495-w.